Industry reports
Editor highlights

Search inside this page

Publishers

All regions

Free Market Research Guides to Download

Drug and Medication Analysis & Statistics, January 2014 (p2)

You might be interested in: drug, vaccine, insulin, more »

» Purchase Premium Reports

31-80 of about 5 000 reports
Fendrix (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022

Fendrix (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • January 2014
  • by Global Data

Fendrix (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022 Summary Hepatitis B, which is caused by the hepatitis B virus (HBV), is characterized by acute or chronic inflammation ...

  • Industries : Drug and Medication
  • Countries : Canada, Spain, Italy, France, Germany, Japan, World, United States, United Kingdom, Europe
Heplisav (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022

Heplisav (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • January 2014
  • by Global Data

Heplisav (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022 Summary Hepatitis B, which is caused by the hepatitis B virus (HBV), is characterized by acute or chronic inflammation ...

  • Industries : Drug and Medication
  • Countries : Canada, Spain, Italy, France, Germany, Japan, World, United States, United Kingdom, Europe
Hexyon (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022

Hexyon (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • January 2014
  • by Global Data

Hexyon (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022 Summary Hepatitis B, which is caused by the hepatitis B virus (HBV), is characterized by acute or chronic inflammation ...

  • Industries : Drug and Medication
  • Countries : Canada, Spain, Italy, France, Germany, World, United States, United Kingdom, Europe, Japan
Infanrix Hexa (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022

Infanrix Hexa (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • January 2014
  • by Global Data

Infanrix Hexa (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022 Summary Hepatitis B, which is caused by the hepatitis B virus (HBV), is characterized by acute or chronic ...

  • Industries : Drug and Medication
  • Countries : Canada, Spain, Italy, France, Germany, World, United States, Europe, Japan
Pediarix (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022

Pediarix (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • January 2014
  • by Global Data

Pediarix (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022 Summary Hepatitis B, which is caused by the hepatitis B virus (HBV), is characterized by acute or chronic inflammation ...

  • Industries : Drug and Medication
  • Countries : World, United States, Canada, Spain, Italy, France, Germany, Japan
Recombivax HB (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022

Recombivax HB (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • January 2014
  • by Global Data

Recombivax HB (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022 Summary Hepatitis B, which is caused by the hepatitis B virus (HBV), is characterized by acute or chronic ...

  • Industries : Drug and Medication
  • Countries : Canada, Spain, Italy, France, Germany, Japan, World, United States, United Kingdom, Europe
Twinrix (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022

Twinrix (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • January 2014
  • by Global Data

Twinrix (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022 Summary Hepatitis B, which is caused by the hepatitis B virus (HBV), is characterized by acute or chronic inflammation ...

  • Industries : Drug and Medication
  • Countries : Canada, Spain, Italy, France, Germany, World, United States, United Kingdom, Europe, Japan
Autoinjectors to 2020 : Devices, Markets, Players, Strategies and Forecasts

Autoinjectors to 2020 : Devices, Markets, Players, Strategies and Forecasts

  • $ 2 850
  • Industry report
  • March 2014
  • by Greystone Research Associates

Syringes that can be prefilled on standard fill-and-finish lines have had a dramatic effect on the way injectable drugs are developed, prescribed and administered. This impact has been accelerated by the ...

  • Industries : Drug and Medication
Parkinson%s Disease: World Drug Industry and Market 2014-2024

Parkinson%s Disease: World Drug Industry and Market 2014-2024

  • $ 2 776
  • Industry report
  • February 2014
  • by Visiongain

Report Details Treating Parkinson's - how you find business trends, R&D, and revenue forecasts See the future of Parkinson's drugs. For those treatments you can get new sales predictions, also exploring ...

  • Industries : Drug and Medication
  • Countries : World, United States
Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2014-2024

Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2014-2024

  • $ 2 776
  • Industry report
  • January 2014
  • by Visiongain

Report Details New study shows you commercial prospects for leading eye drug producers What does the future hold for top companies in the pharma ophthalmics industry? Visiongain's brand new report shows ...

  • Industries : Drug and Medication
  • Countries : United States
Paclitaxel: Pipeline™ Developer: Patent Report

Paclitaxel: Pipeline™ Developer: Patent Report

  • $ 2 580
  • Industry report
  • March 2014
  • by GenericsWeb

0

  • Industries : Drug and Medication
Docetaxel: Pipeline™ Developer: Patent Report

Docetaxel: Pipeline™ Developer: Patent Report

  • $ 2 529
  • Industry report
  • March 2014
  • by GenericsWeb

0

  • Industries : Drug and Medication
Doxorubicin: Pipeline™ Developer: Patent Report

Doxorubicin: Pipeline™ Developer: Patent Report

  • $ 2 529
  • Industry report
  • March 2014
  • by GenericsWeb

0

  • Industries : Drug and Medication
Global Hypertension Drugs Market 2014-2018

Global Hypertension Drugs Market 2014-2018

  • $ 2 500
  • Industry report
  • April 2014
  • by Infiniti Research Limited

About Hypertension Drugs Hypertension, also referred as arterial hypertension or high BP, is a chronic medical condition in which the arterial blood pressure is elevated to an undesired level. Lifestyle ...

  • Industries : Drug and Medication
  • Countries : World
Global Therapeutic Vaccines Market 2014-2018

Global Therapeutic Vaccines Market 2014-2018

  • $ 2 500
  • Industry report
  • March 2014
  • by Infiniti Research Limited

About Therapeutic Vaccines A therapeutic vaccine is a biological combination developed to improve immunity by inducing an attack against a diseased cell or tissue. This differs from prophylactic vaccines, ...

  • Industries : Drug and Medication
  • Countries : World
Global Pain Management Drugs Market 2014-2018

Global Pain Management Drugs Market 2014-2018

  • $ 2 500
  • Industry report
  • March 2014
  • by Infiniti Research Limited

TechNavio's analysts forecast the Global Pain Management Drugs market will grow at a CAGR of 3.84 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing ...

  • Industries : Drug and Medication
  • Countries : World
Global Dermatological Drugs Market 2014-2018

Global Dermatological Drugs Market 2014-2018

  • $ 2 500
  • Industry report
  • March 2014
  • by Infiniti Research Limited

TechNavio's analysts forecast the Global Dermatological Drugs market to grow at a CAGR of 4.29 percent over the period 2013-2018. One of the key factors contributing to this market's growth is an increase ...

  • Industries : Drug and Medication
  • Countries : World
Pharmaceutical Industry in China - Cutting-Edge Analysis of Multinational and Chinese Pharma Companies, Industry Trends, Environment, Regulation, Market Drivers, Restraints, Opportunities & Challenges

Pharmaceutical Industry in China - Cutting-Edge Analysis of Multinational and Chinese Pharma Companies, Industry Trends, Environment, Regulation, Market Drivers, Restraints, Opportunities & Challenges

  • $ 2 500
  • Industry report
  • March 2014
  • by Kelly Scientific Publications

“Pharmaceutical Industry China - Cutting-Edge Analysis of Multinational and Chinese Biopharma Companies, Industry Trends, Environment, Regulation, Market Drivers, Restraints, Opportunities & Challenges” ...

  • Industries : Drug and Medication
  • Countries : China
Global Osteoporosis Drugs Market 2014-2018

Global Osteoporosis Drugs Market 2014-2018

  • $ 2 500
  • Industry report
  • January 2014
  • by Infiniti Research Limited

TechNavio's analysts forecast the Global Osteoporosis Drugs market to grow at a CAGR of 3.98 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing ...

  • Industries : Drug and Medication
  • Countries : World
Hematological Cancers Drug Pipeline Update 2014

Hematological Cancers Drug Pipeline Update 2014

  • $ 2 999
  • Industry report
  • March 2014
  • by Bioseeker

Unmet needs across the hematological malignancies remain high, with most traditional therapies conferring low levels of specificity and high toxicity. There are today 438 companies plus partners developing ...

  • Industries : Drug and Medication
PI3K-Akt Signaling Pathway in Cancer Drug Pipeline Update 2014

PI3K-Akt Signaling Pathway in Cancer Drug Pipeline Update 2014

  • $ 2 999
  • Industry report
  • March 2014
  • by Bioseeker

The phosphatidylinositol 3' -kinase(PI3K)-Akt signaling pathway is activated by many types of cellular stimuli or toxic insults and regulates fundamental cellular functions such as transcription, translation, ...

  • Industries : Drug and Medication
Isotretinoin: Pipeline™ Developer: Patent Report

Isotretinoin: Pipeline™ Developer: Patent Report

  • $ 2 266
  • Industry report
  • March 2014
  • by GenericsWeb

0

  • Industries : Drug and Medication
Moxidectin (Vet): Pipeline™ Developer: Patent Report

Moxidectin (Vet): Pipeline™ Developer: Patent Report

  • $ 2 266
  • Industry report
  • March 2014
  • by GenericsWeb

0

  • Industries : Drug and Medication
Levofloxacin: Pipeline™ Developer: Patent Report

Levofloxacin: Pipeline™ Developer: Patent Report

  • $ 2 266
  • Industry report
  • March 2014
  • by GenericsWeb

0

  • Industries : Drug and Medication
Pantoprazole: Pipeline™ Developer: Patent Report

Pantoprazole: Pipeline™ Developer: Patent Report

  • $ 2 266
  • Industry report
  • March 2014
  • by GenericsWeb

0

  • Industries : Drug and Medication
Rosiglitazone: Pipeline™ Developer: Patent Report

Rosiglitazone: Pipeline™ Developer: Patent Report

  • $ 2 266
  • Industry report
  • March 2014
  • by GenericsWeb

0

  • Industries : Drug and Medication
Pioglitazone: Pipeline™ Developer: Patent Report

Pioglitazone: Pipeline™ Developer: Patent Report

  • $ 2 266
  • Industry report
  • March 2014
  • by GenericsWeb

0

  • Industries : Drug and Medication
Meropenem: Pipeline™ Developer: Patent Report

Meropenem: Pipeline™ Developer: Patent Report

  • $ 2 266
  • Industry report
  • March 2014
  • by GenericsWeb

0

  • Industries : Drug and Medication
Moxifloxacin: Pipeline™ Developer: Patent Report

Moxifloxacin: Pipeline™ Developer: Patent Report

  • $ 2 266
  • Industry report
  • March 2014
  • by GenericsWeb

0

  • Industries : Drug and Medication
2014 Deep Research Report on Global and China Insulin Industry

2014 Deep Research Report on Global and China Insulin Industry

  • $ 2 200
  • Industry report
  • April 2014
  • by QY Research Group

Summary "2014 Deep Research Report on Global and China Insulin Industry" was professional and depth research report on Global and China Insulin industry. The report firstly introduced Insulin basic information ...

  • Industries : Drug and Medication
  • Countries : China, World

» View Public Reports

About 12 000 reports

The British Antibiotic Sector

  • Industry report
  • April 2014
  • 37 pages

... Research to have a major impact in reducing the burden of the disease) priority medicines for europe and the world, warren kaplan and richard laing, world health organisation, department of essential drugs ...


» Read our Company Profiles

85 Companies

GlaxoSmithKline P.L.C.

United States

Johnson and Johnson

United States

Novartis Inc.

Switzerland

GlaxoSmithKline PLC

United Kingdom

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.